1. Introduction to the Project

1.1 Introduction to technical achievements

The project has developed stem cell biotechnology, and currently has mastered the extraction, preparation, research and development, and storage capabilities of various stem cells, immune cells, and their derivatives, mainly applied in cell storage, cell technology output and support, cosmetologyand anti-aging.

1.2 Technical analysis and advantages

1.2.1 Core technical analysis

The cell technology has obtained technical authorization from the Joint Laboratory of Japan, and the ownership of the technology belongs to Jilin Hezhong Biotechnology Co., Ltd., which has accumulated more than ten years of technology; it holds the pancreatic islets β Cell patent (diabetes), chondrocyte preparation technology (knee joint disease); it masters the extraction, preparation, research and development, and storage capabilities of various stem cells, immune cells, and their derivatives.

1.2.2 Technological innovation and advantages

Jilin Hezhong Biotechnology Co., Ltd. is a national certified “new and high-tech enterprise”, a member unit of the United Nations International Academy of Ecology and Life Safety Sciences, a cell preparation center of the Asia Pacific Branch, and a unit for technology achievement commercialization and project implementation. Hezhong Co., Ltd. has established or cooperated to establish operating companies and medical institutions in multiple regions such as Haikou, Boao, Shenzhen, Beijing, Hubei, Jilin, and Taipei. It has provided relevant services to over a thousand people and institutions both domestically and internationally.

1.3 Main products and applications of technical achievements

Cell storage: mainly for adult immune cell storage, with the purpose of life insurance; immune cell storage has a wide audience (the vast majority of people aged 18-60) and can be stored multiple times.

Technical output and support: it provides technical support and product OEM for related enterprises and industrial platforms, including the cell technology and gene technology.

Cosmetology and anti-aging: using cellular derivatives and traditional techniques for skin care and anti-aging applications.

1.4 Technical achievement commercialization stage

The project is in the industrialization stage.

1.5 Technical team

Core leadership team: The core team of the company has over ten years of industry experience, fully understands relevant technologies and market conditions, and is able to fully grasp the strategic layout.

The technical team consists of several scientific professionals in the relevant fields of the industry, including a doctoral supervisor at the Graduate School of Tsinghua University, a deputy director of the Department of Divine Surgery at the First Hospital of Jilin University, a PhD in Bioengineering from the Capital Medical University, and a PhD from the Military Medical University.

Academicians and professors: With guidance and support from multiple academicians, professors, and experts who are proficient in the cutting-edge technology, including Asian academician Lude, foreign academician of the Russian Academy of Engineering (responsible expert for national major new drug development plans), and Professor Xie He (proficient in donkey serum separation and extraction methods).

Liu Rongbo, the main person in charge, is the Chairman of Jilin Hezhong Biotechnology Co., Ltd. and the Executive Member of the Department of Life Sciences of the United Nations International Academy of Ecological Life Safety (Asia Pacific Branch); with over ten years of industry experience in the field of cell technology health services, the company has expanded its layout to multiple regions such as Haikou, Shenzhen, Hubei, Jiangxi, Beijing, Jilin, and Taipei.

2. Market Potential Analysis

The company has jointly established a platform company with State-owned enterprises under China Resources and state-owned enterprises under Jilin Provincial Government, responsible for biotechnology support, procurement of biological materials, and reserve of combat readiness biological products. Boao International Outpatient Clinic · Introduction of New Drugs, construction of an international diagnosis and treatment center in Boao, introduction of overseas resources (Japan, Taiwan), smooth import and approval of new drugs in accordance with the “National Nine Articles” and “New National Nine Articles” policies, and later introduction of new drugs in the province, providing international commercial insurance assistance, and continuous development of cell technology. With the donkey serum separation and extraction technology, in deep cooperation with China Donkey Group, it provides technical support. The Hi-TCR-T cell technology and heat shock protein gp96 technology were first applied in Boao. Tibetan Medicine and Traditional Chinese Medicine Union: the company has currently established the Tibetan Medicine Diagnosis and Treatment Center in Hainan, introducing Tibetan medicine and providing multiple medication channels for Tibetan medicine; there is the joint application of the cell technology and traditional Chinese medicine therapy in traditional Chinese medicine, as well as the scientific research collaboration between traditional Chinese medicine and cell technology.

3. Financing Needs and Financing Purposes

The project is planned to invest 1 million yuan. It collaborates with central and provincial state-owned enterprises to establish a platform company, launch the Northeast China Revitalization Strategy Project, and assume technical and reserve responsibilities. By that time, the funds will have been used for the procurement of equipment and supplies, as well as the preparation of biological reagents. It will build an international diagnosis and treatment center in Boao, introducing the resources from Taiwan and Japan and utilizing Boao’s pre-licensing policies for new drug introduction, insurance assistance, and new technology research, etc. By that time, the funds will have been used for the center’s infrastructure construction and facility procurement.

4. Analysis of Technical Achievements and Benefits

4.1 Economic benefits

The biotechnology company jointly established with State-owned enterprises in Jiangxi has completed registration and begun preliminary planning. Parallel companies will be established in Changchun in the future. It is estimated that the first year of construction and production in Jiangxi and Changchun will be valued at 10 million yuan.

4.2 Social benefits

The research on biological stem cells provides new ideas and methods for the medical field. By studying the characteristics and mechanisms of action of biological stem cells, we can gain a deeper understanding of the essence of life and the mechanisms of disease occurrence, providing new avenues for disease prevention, diagnosis, and treatment.

The research and application of biological stem cells have also brought tremendous changes to people’s quality of life. Firstly, the application of biological stem cells in the field of beauty, such as skin regeneration and anti-aging, can improve people’s appearance and health status, enhance their confidence and quality of life. Secondly, the application of biological stem cells in the medical field, such as tissue engineering and organ transplantation, can solve some problems that traditional medical methods cannot solve and improve people’s quality of life.

The research and application of biological stem cells have also driven economic development. Firstly, the research on biological stem cells requires a significant investment of funds and manpower, which provides opportunities for research institutions and enterprises to develop and innovate, promoting the development of technology. Secondly, the application of biological stem cells has also brought enormous commercial values such as the increasing demand in cosmetology, medical and other fields, which has driven the development of related industries.

The research and application of biological stem cells can also improve the social environment. Firstly, by studying and applying biological stem cells, we can better understand and address some social issues such as population aging and disease burden. Secondly, by promoting the development and application of the biological stem cell technology, more employment opportunities and economic benefits can be created for society, promoting sustainable development.

5. Contact Method

Contact person: Li Na

Tel: 13756504575